The Ballymena firm headed by Irwin Armstrong makes and packages a range which includes ovulation, menopause and pregnancy tests as well as blood pressure and diabetes monitors and other personal health diagnostic kits under the company’s SURESIGN brand, says the initial contract opens the door to further business in Latin America.
“We are very pleased to have secured this initial contract to supply Uruguay with kits which they will brand themselves,” says Mr Armstrong.
“The SURESIGN brand has been well established in the UK, Ireland and Europe for many years and our reputation for accuracy will have been key to winning this work,” he says.
The distribution deal with its Uruguayan partner means CIGA Healthcare can now target other Central and Latin American countries including Honduras, Panama, Guatemala, Paraguay, Bolivia, El Salvador, Costa Rica and Nicaragua.
The Ballymena firm was established in 2005 and is a member of the Rapid Test Consortium (RTC) which includes Abingdon Health, BBI Solutions, CIGA Healthcare and Omega Diagnostics, and it has worked closely with Oxford University. In 2020, the RTC developed the AbC-19 rapid test to meet UK government requirements for a rapid testing solution. The government ordered one million of the UK-RTC’s rapid tests in October 2020. The Abc19 Covid-19 neutralising antibody test is one of the most accurate tests on the market.
The firm recently agreed a distribution deal with US manufacturer to sell the revolutionary new clean air PlasmaGuard Pro device. The clean air device which has already been installed in hundreds of bars, restaurants, offices and public places, destroys 99.9% of contaminates and viruses including the Coronavirus.
In 2012, subsidiary CIGA Healthcare LLC was established as part of the company’s expansion into the American market. CIGA Healthcare now exports to more than 60 countries across the globe.
The company employs 28 at its Ballymena site.
Advertisement
